QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online September 30, 2004
doi: 10.1242/10.1242/dev.01383

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in Development Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Coppola, V. Articles by Tessarollo, L. Search for Related Content PubMed PubMed Citation Articles by Coppola, V. Articles by Tessarollo, L. Social Bookmarking                         What's this?

Ablation of TrkA function in the immune system causes B cell abnormalities

¹ Neural Development Group, Mouse Cancer Genetics Program, NCI, NIH, Frederick, MD 21702-1201, USA
² Experimental Immunology Branch, NCI, NIH, Bethesda, MD 20892, USA
³ Aventis Pharmaceuticals, Bridgewater, NJ 08807-0800, USA

^* Author for correspondence (e-mail: tessarol{at}ncifcrf.gov)

Accepted 2 August 2004

The nerve growth factor (NGF) receptor TrkA is widely expressed in non-neural tissues suggesting pleiotropic functions outside the nervous system. Based on pharmacological and immuno-depletion experiments, it has been hypothesized that NGF plays an important role in the normal development and function of the immune system. However, attempts to unravel these functions by conventional gene targeting in mice have been hampered by the early postnatal lethality caused by null mutations. We have developed a novel `reverse conditional' gene targeting strategy by which TrkA function is restored specifically in the nervous system. Mice lacking TrkA in non-neuronal tissues are viable and appear grossly normal. All major immune system cell populations are present in normal numbers and distributions. However, mutant mice have elevated serum levels of certain immunoglobulin classes and accumulate B1 cells with aging. These data, confirmed in a classical reconstitution model using embryonic fetal liver from TrkA-null mice, demonstrate that endogenous NGF modulates B cell development through TrkA in vivo. Furthermore, they demonstrate that many of the dramatic effects previously reported by pharmacological or immuno-depletion approaches do not reflect physiological developmental roles of TrkA in the immune system.

Key words: TrkA, NGF, Immune system, Mouse

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in Development:

NGF and the immune system

Development 2004 131: e2005. [Full Text]  

NGF and the immune system

Development 2004 131: e2005. [Full Text]  

This article has been cited by other articles:

				A. Caporali and C. Emanueli Cardiovascular Actions of Neurotrophins Physiol Rev, January 1, 2009; 89(1): 279 - 308. [Abstract] [Full Text] [PDF]

				A. P. Fernandez, J. Serrano, L. Tessarollo, F. Cuttitta, and A. Martinez Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions PNAS, August 26, 2008; 105(34): 12581 - 12586. [Abstract] [Full Text] [PDF]

				L. F Reichardt Neurotrophin-regulated signalling pathways Phil Trans R Soc B, September 29, 2006; 361(1473): 1545 - 1564. [Abstract] [Full Text] [PDF]

				V. Coppola, C. A. Barrick, S. Bobisse, M. C. Rodriguez-Galan, M. Pivetta, D. Reynolds, O. M. Z. Howard, M. E. Palko, P. F. Esteban, H. A. Young, et al. The scaffold protein cybr is required for cytokine-modulated trafficking of leukocytes in vivo. Mol. Cell. Biol., July 1, 2006; 26(14): 5249 - 5258. [Abstract] [Full Text] [PDF]

				R. N. Pearse, S. L. Swendeman, Y. Li, D. Rafii, and B. L. Hempstead A neurotrophin axis in myeloma: TrkB and BDNF promote tumor-cell survival Blood, June 1, 2005; 105(11): 4429 - 4436. [Abstract] [Full Text] [PDF]